https://www.indianpharmapost.com/supriya-lifescience-reports-robust-q1-fy25-results-with-217-revenue-growth-160222024-08-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/healthcred-secures-us-12-million-in-seed-funding-160232024-08-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizer-announces-results-of-abrysvo-for-rsv-in-immunocompromised-adults-160242024-08-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-receives-usfda-final-approval-for-dabigatran-etexilate-capsules-110-mg-160252024-08-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/ashland-completes-second-expansion-of-viatel-bioresorbable-polymers-manufacturing-and-rd-lab-in-ireland-160262024-08-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/enhertu-approved-in-china-for-patients-with-previously-treated-her2-positive-advanced-or-metastatic-gastric-cancer-160272024-08-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/morepen-labs-q1-fy25-profit-surges-147-to-rs-3617-cr-160282024-08-13T00:00:00+05:30always0.9